The main obstacle preventing health systems from prioritizing AI over the next 3-5 years is not a lack of AI products in the market, but rather the challenges of integrating the technology into their existing workflows, and the uncertainty in measuring its return on investment (ROI). Newton’s Tree’s end-to-end AI governance platform delivers the necessary transparency and holistic oversight, empowering your multidisciplinary AI Governance Committee to drive confident AI adoption at scale across clinical and operational pathways.

In this episode, host Sandy Vance sits with Haris Shuaib, the CEO of Newton’s Tree, to discuss the speed at which AI is advancing and whether this pace is safe. They unpack what responsible, scalable AI governance really looks like. From hidden risks in data quality to the subtle ways AI behavior can drift over time, Haris breaks down why checks and balances aren’t just a compliance exercise. They’re essential to patient safety and organizational trust.

In this episode, they talk about:

• How Newton’s Tree helps governance committees confidently scale AI across clinical and operational pathways
• Why so many organizations struggle with AI implementation—and where things most often break down
• What an effective process looks like for evaluating whether AI oversight is actually working
• The three things Newton’s Tree continuously monitors: data quality, AI behavior, and clinical decision risk
• Why closing the feedback loop is critical right now
• Practical advice for CIOs navigating AI adoption—and how Newton’s Tree supports them
• The role of registries and observatories in responsible AI deployment
• How to ensure AI systems are safe and effective before they’re put into real-world use

A Little About Haris:

Haris Shuaib is Founder and CEO of Newton’s Tree, a startup dedicated to AI transformation at scale in health and care. He is Director of the Fellowships in Clinical Artificial Intelligence, the first clinical training programme for healthcare professionals to develop practical AI skills. He is also a Consultant Clinical Scientist and former Head of the Clinical Scientific Computing section at Guy’s & St Thomas’ NHS FT. Finally, he also holds a NIHR Doctoral Research Fellowship, where he is leading a national multi-centre trial to see whether AI can improve the treatment of glioblastoma.